Stock listing
IMA Stock Price, News, Filings & Events — Imagenebio, Inc.
Selected listing: IMA · NASDAQ · USD · US
This page tracks Imagenebio, Inc.'s IMA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IMA:NASDAQ. IMA:NASDAQ is the stock-level entry point for investors researching Imagenebio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Imagenebio, Inc. is a public company traded under the ticker IMA in the American market. The company has a market capitalization of approximately $66 million. It is focused on developing innovative solutions in the biotechnology sector.

- Ticker
- IMA:NASDAQ
- Asset type
- Stock
- Market cap
- $55.1M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Imagenebio, Inc. IMA:NASDAQ stock context
This page tracks Imagenebio, Inc.'s IMA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IMA:NASDAQ. IMA:NASDAQ is the stock-level entry point for investors researching Imagenebio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Imagenebio, Inc. is a public company traded under the ticker IMA in the American market. The company has a market capitalization of approximately $66 million. It is focused on developing innovative solutions in the biotechnology sector.
Latest news from Imagenebio, Inc.
ImageneBio to Participate in H.C. Wainwright 28th Annual Global Investment Conference in New York
September 8, 2026
ImageneBio Reports Inducement Grants under Nasdaq Listing Rule 5635(4)
August 18, 2026
ImageneBio Reports Second Quarter 2026 Financial Results
August 5, 2026
ImageneBio Appoints Matt Robbins as General Counsel
July 7, 2026
ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York
May 27, 2026
Research Imagenebio, Inc.
Imagenebio, Inc. investor report
Review AI stock analysis and investor report context for IMA:NASDAQ.
Imagenebio, Inc. company profile
View the public company page for Imagenebio, Inc. on 6ix.
Imagenebio, Inc. news
Read company news and market updates connected to Imagenebio, Inc..
Imagenebio, Inc. investor events
Find investor webinars, events, and replay context for Imagenebio, Inc..